Natural killer (NK) cells became markedly better at killing cancer cells after scientists removed key gene targets identified through a new genome-wide CRISPR screening tool, according to new research ...

Bio corporation CHA Biotech is working to secure mass production technology essential for the development and commercialization of CAR-NK therapies that meet global standards. CAR-NK cell therapy is a ...

Wugen has raised $115 million, tapping a Fidelity-led syndicate to fund its pursuit of FDA approval for the first off-the-shelf CAR-T for T-cell malignancies. A pivotal trial is underway, putting the ...

The authors argue that male-biased expression of Cyp17a2 is implicated in mediating infection levels through STING and USP8 activity regulation. Thus, this study highlights an unexpected factor ...

A 'game changing' new technique which wipes out rogue cells responsible for autoimmune conditions may offer the hope of a one-off treatment for many debilitating diseases. Around four million people ...